Arecor Therapeutics (AREC) Competitors

Arecor Therapeutics logo
GBX 72 -4.00 (-5.26%)
As of 11/20/2026 09:56 AM Eastern

AREC vs. AURA, NEO, NCCL, ARMS, and BHR

Should you buy Arecor Therapeutics stock or one of its competitors? Arecor Therapeutics's main competitors and comparable companies include Aura Energy (AURA), Neo Energy Metals (NEO), Ncondezi Energy (NCCL), Asia Resource Minerals (ARMS), and Beacon Hill Resources (BHR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "coal & consumable fuels" industry.

How does Arecor Therapeutics compare to Aura Energy?

Arecor Therapeutics (LON:AREC) and Aura Energy (LON:AURA) are both small-cap energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

6.9% of Arecor Therapeutics shares are held by institutional investors. Comparatively, 11.3% of Aura Energy shares are held by institutional investors. 4.1% of Arecor Therapeutics shares are held by insiders. Comparatively, 7.3% of Aura Energy shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Arecor Therapeutics had 1 more articles in the media than Aura Energy. MarketBeat recorded 1 mentions for Arecor Therapeutics and 0 mentions for Aura Energy. Arecor Therapeutics' average media sentiment score of 0.00 equaled Aura Energy'saverage media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Aura Energy Neutral

Aura Energy has lower revenue, but higher earnings than Arecor Therapeutics. Aura Energy is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£890K36.65-£10.68M£1.0072.00
Aura EnergyN/AN/A-£16.15K-£1.18N/A

Arecor Therapeutics has a beta of -0.18, indicating that its stock price is 118% less volatile than the broader market. Comparatively, Aura Energy has a beta of -0.35, indicating that its stock price is 135% less volatile than the broader market.

Aura Energy has a net margin of 0.00% compared to Arecor Therapeutics' net margin of -200.00%. Arecor Therapeutics' return on equity of 3.75% beat Aura Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics-200.00% 3.75% -37.31%
Aura Energy N/A -17.68%-8.03%

Summary

Arecor Therapeutics beats Aura Energy on 6 of the 11 factors compared between the two stocks.

How does Arecor Therapeutics compare to Neo Energy Metals?

Arecor Therapeutics (LON:AREC) and Neo Energy Metals (LON:NEO) are both small-cap energy companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

In the previous week, Arecor Therapeutics had 1 more articles in the media than Neo Energy Metals. MarketBeat recorded 1 mentions for Arecor Therapeutics and 0 mentions for Neo Energy Metals. Arecor Therapeutics' average media sentiment score of 0.00 equaled Neo Energy Metals'average media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Neo Energy Metals Neutral

Neo Energy Metals has lower revenue, but higher earnings than Arecor Therapeutics. Neo Energy Metals is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£890K36.65-£10.68M£1.0072.00
Neo Energy MetalsN/AN/A-£4.24M£0.181.95

6.9% of Arecor Therapeutics shares are owned by institutional investors. Comparatively, 4.4% of Neo Energy Metals shares are owned by institutional investors. 4.1% of Arecor Therapeutics shares are owned by insiders. Comparatively, 37.4% of Neo Energy Metals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Neo Energy Metals has a net margin of 0.00% compared to Arecor Therapeutics' net margin of -200.00%. Neo Energy Metals' return on equity of 3,144.85% beat Arecor Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics-200.00% 3.75% -37.31%
Neo Energy Metals N/A 3,144.85%N/A

Arecor Therapeutics has a beta of -0.18, indicating that its stock price is 118% less volatile than the broader market. Comparatively, Neo Energy Metals has a beta of 5.008, indicating that its stock price is 401% more volatile than the broader market.

Summary

Neo Energy Metals beats Arecor Therapeutics on 6 of the 11 factors compared between the two stocks.

How does Arecor Therapeutics compare to Ncondezi Energy?

Ncondezi Energy (LON:NCCL) and Arecor Therapeutics (LON:AREC) are both small-cap energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

In the previous week, Arecor Therapeutics had 1 more articles in the media than Ncondezi Energy. MarketBeat recorded 1 mentions for Arecor Therapeutics and 0 mentions for Ncondezi Energy. Ncondezi Energy's average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Ncondezi Energy Neutral
Arecor Therapeutics Neutral

9.7% of Ncondezi Energy shares are owned by institutional investors. Comparatively, 6.9% of Arecor Therapeutics shares are owned by institutional investors. 34.3% of Ncondezi Energy shares are owned by company insiders. Comparatively, 4.1% of Arecor Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Ncondezi Energy has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market. Comparatively, Arecor Therapeutics has a beta of -0.18, meaning that its stock price is 118% less volatile than the broader market.

Ncondezi Energy has a net margin of 0.00% compared to Arecor Therapeutics' net margin of -200.00%. Arecor Therapeutics' return on equity of 3.75% beat Ncondezi Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Ncondezi EnergyN/A -15.23% -5.36%
Arecor Therapeutics -200.00%3.75%-37.31%

Ncondezi Energy has higher earnings, but lower revenue than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ncondezi EnergyN/AN/A-£2.05MN/AN/A
Arecor Therapeutics£890K36.65-£10.68M£1.0072.00

Summary

Ncondezi Energy beats Arecor Therapeutics on 6 of the 10 factors compared between the two stocks.

How does Arecor Therapeutics compare to Asia Resource Minerals?

Asia Resource Minerals (LON:ARMS) and Arecor Therapeutics (LON:AREC) are both energy companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.

6.9% of Arecor Therapeutics shares are owned by institutional investors. 4.1% of Arecor Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Asia Resource Minerals has a net margin of 0.00% compared to Arecor Therapeutics' net margin of -200.00%. Arecor Therapeutics' return on equity of 3.75% beat Asia Resource Minerals' return on equity.

Company Net Margins Return on Equity Return on Assets
Asia Resource MineralsN/A N/A N/A
Arecor Therapeutics -200.00%3.75%-37.31%

In the previous week, Arecor Therapeutics had 1 more articles in the media than Asia Resource Minerals. MarketBeat recorded 1 mentions for Arecor Therapeutics and 0 mentions for Asia Resource Minerals. Asia Resource Minerals' average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Asia Resource Minerals Neutral
Arecor Therapeutics Neutral

Asia Resource Minerals has higher earnings, but lower revenue than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Asia Resource MineralsN/AN/AN/AN/AN/A
Arecor Therapeutics£890K36.65-£10.68M£1.0072.00

Summary

Arecor Therapeutics beats Asia Resource Minerals on 5 of the 7 factors compared between the two stocks.

How does Arecor Therapeutics compare to Beacon Hill Resources?

Arecor Therapeutics (LON:AREC) and Beacon Hill Resources (LON:BHR) are both energy companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

6.9% of Arecor Therapeutics shares are owned by institutional investors. 4.1% of Arecor Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Beacon Hill Resources has a net margin of 0.00% compared to Arecor Therapeutics' net margin of -200.00%. Arecor Therapeutics' return on equity of 3.75% beat Beacon Hill Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics-200.00% 3.75% -37.31%
Beacon Hill Resources N/A N/A N/A

In the previous week, Arecor Therapeutics had 1 more articles in the media than Beacon Hill Resources. MarketBeat recorded 1 mentions for Arecor Therapeutics and 0 mentions for Beacon Hill Resources. Arecor Therapeutics' average media sentiment score of 0.00 equaled Beacon Hill Resources'average media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Beacon Hill Resources Neutral

Beacon Hill Resources has lower revenue, but higher earnings than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£890K36.65-£10.68M£1.0072.00
Beacon Hill ResourcesN/AN/AN/AN/AN/A

Summary

Arecor Therapeutics beats Beacon Hill Resources on 5 of the 7 factors compared between the two stocks.

Get Arecor Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AREC vs. The Competition

MetricArecor TherapeuticsOil, Gas & Consumable Fuels IndustryEnergy SectorLON Exchange
Market Cap£32.62M£10.55B£9.18B£2.39B
Dividend YieldN/A6.52%6.35%5.11%
P/E Ratio72.0020.3720.7922.78
Price / Sales36.654.564.004.91
Price / Cash5.0720.3019.4820.23
Price / Book4.342.602.412.40
Net Income-£10.68M£5.28B£4.35B£5.88B
7 Day Performance-7.40%-6.78%-6.80%-3.59%
1 Month Performance-13.09%-11.84%-11.26%-3.91%
1 Year Performance-3.82%15.95%16.80%5.17%

Arecor Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AREC
Arecor Therapeutics
N/AGBX 72
-5.3%
N/A-3.8%£32.62M£890K72.0010
AURA
Aura Energy
N/AGBX 4
+9.6%
N/A-53.2%£40.70MN/AN/A50
NEO
Neo Energy Metals
N/AGBX 0.32
-14.7%
N/AN/A£9.89MN/A1.762,100
NCCL
Ncondezi Energy
N/AN/AN/AN/A£4.67MN/AN/A4
ARMS
Asia Resource Minerals
N/AN/AN/AN/A£0.00N/AN/A147,000

Related Companies and Tools


This page (LON:AREC) was last updated on 11/22/2026 by MarketBeat.com Staff.
From Our Partners